Category:
Active Pharmaceutical Ingredients
CAS NO:
1195765-45-7
Standard:
In-house Standards,
Dalafenib is a novel oral kinase inhibitor under clinical investigation for oncology. It targets specific tyrosine kinases to inhibit tumor cell proliferation. Molecular Formula: C25H24ClN7O; CAS No.: 2190876-33-0.
Strictly regulated as an investigational new drug (IND). Storage requires controlled temperature (-20°C) and inert atmosphere. Handling demands PPE due to potential cytotoxicity.